Related Experiment Video

Updated: Aug 9, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Targeting retinoblastoma protein for degradation by proteasomes

Haoqiang Ying1, Zhi-Xiong J Xiao

  • 1Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, USA.

Cell Cycle (Georgetown, Tex.)
|March 23, 2006
PubMed

Insights

MDM2 targets the retinoblastoma protein (Rb) for degradation via the proteasome, a novel ubiquitin-independent pathway. This mechanism is crucial for cancer development and offers potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Biology

Background:

  • Retinoblastoma protein (Rb) inactivation is critical in human tumorigenesis.
  • While Rb phosphorylation is well-studied, proteasome-mediated degradation remains unclear.
  • Several viral and cellular oncoproteins target Rb for degradation through proteasome pathways.

Purpose of the Study:

  • To investigate the largely unknown mechanisms of proteasome-mediated retinoblastoma protein (Rb) degradation.
  • To elucidate the role of MDM2 oncoprotein in Rb protein degradation.
  • To understand the implications of MDM2-mediated Rb degradation in human cancer development.

Main Methods:

  • Investigated the interaction between MDM2 and the 20S proteasome C8 subunit.
  • Examined the effect of MDM2 on Rb-C8 interaction and subsequent Rb degradation.
  • Utilized MDM2 knockdown to assess the impact on Rb levels and DNA synthesis.

Main Results:

  • MDM2 binds to the C8 subunit of the 20S proteasome, promoting Rb-C8 interaction.
  • This interaction leads to proteasome-dependent, ubiquitin-independent degradation of Rb.
  • MDM2 knockdown results in hypophosphorylated Rb accumulation and inhibited DNA synthesis.

Conclusions:

  • MDM2 targets Rb for degradation through a novel ubiquitin-independent proteasome pathway.
  • This mechanism highlights a common neoplastic strategy involving Rb proteasomal degradation in human cancers.
  • Targeting Rb degradation by proteasomes presents a potential therapeutic avenue for cancer treatment.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...